Blue Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Blue Capital's GSK Position: Q3 2026 in Review
Blue Capital reduced its GSK (GSK) stake by 0.68% in Q3 2026, selling an estimated $1.58K and leaving 4,556 shares worth $219K. The position accounts for 0.14% of the portfolio, ranked #132.
Blue Capital first reported a position in GSK in Q1 2026 and has held it in 3 quarters since. The position peaked at $240K in Q2 2026. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Blue Capital held 4,556 shares of GSK worth $219K as of Q3 2026.
- Blue Capital sold 31 GSK shares in Q3 2026, an estimated $1.58K.
- GSK made up 0.14% of Blue Capital's portfolio in Q3 2026, its #132 holding.
- Blue Capital first reported a position in GSK in Q1 2026 and has held it in 3 quarters since.
- Blue Capital's GSK position peaked at $240K in Q2 2026.
- 854 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Blue Capital's 13F filing for Q3 2026, filed 13 Oct 2026.